
Please try another search
Clarus (NASDAQ:CLAR) Therapeutics (CRXT) reported Q1 EPS of ($0.61), $0.21 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $4 million versus the consensus estimate of...
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Consumer Services and Healthcare sectors led shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. stocks were mixed after the close on Wednesday, as gains in the Healthcare, Financials and Utilities sectors led shares higher while losses in the Consumer Services, Technology...
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Financials, Technology and Consumer Services sectors led shares lower. At the close in NYSE, the Dow Jones...
Clarus (NASDAQ:CLAR) Therapeutics Holdings Inc (NASDAQ:CRXT) reported Q4 EPS of ($0.19), $0.49 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $4.6 million versus the...
Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Oil & Gas, Utilities and Financials sectors led shares higher while losses in the Technology, Consumer Services and...
Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Consumer Services, Financials and Technology sectors led shares lower. At the close in NYSE, the Dow Jones...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review